WVXU: Researchers look to variations of psychedelic drugs as the future of mental health treatment
UC expert says research shows promise for improving treatment for mental health disorders
University of Cincinnati researchers are collaborating with researchers at Miami University to explore ways that psychedelic drugs could be used as treatments for a variety of mental illnesses. Andrew Jones, assistant professor of chemical, paper and biomedical engineering at Miami University, has successfully manufactured psilocybin in the lab. He is sharing those compounds with Eric Wohleb, PhD, of the Department of Pharmacology and Systems Physiology at the UC College of Medicine the compounds to test in Wholeb's lab.
WVXU produced a story on the research in which Wohleb will soon expand his research to study new compounds in lab-manufactured magic mushroomsto test their effectiveness in treating mental illness in animal models.
Eric Wohleb, PhD, and Christina Singh, research fellow/Photo/Colleen Kelley/UC Marketing + Brand
“That would kind of be the first pass at whether we see any beneficial effects of some of the compounds,” Wohleb said. “There are a few hurdles to jump through as far as DEA regulations and those types of things that we’re going to have to take care of but it’s a nice way because we’re relatively close and we have the capacity to collaborate.”
WVXU reported that one in four people in the U.S. are affected by mental disorders. Psychedelics could potentially help treat depression, anxiety, PTSD, obsessive-compulsive disorder, addiction, anorexia, bulimia, and more, according to Wohleb.
“An individual suffering from PTSD might also have a lot of depressive symptoms or anxiety symptoms and so finding these compounds that can change or alleviate symptoms across multiple disorders I think is really profound.”
Wohleb says there has been a fundamental shift in how psychiatry operates and it’s exciting to be working in this space.
Lead photo of Eric Wohleb, Andrew Jones and UC graduate student Alex Kuhn/Ann Thompson/WVXU
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
University of Cincinnati gets $1.1M for AI physician training
January 30, 2026
The University of Cincinnati College of Medicine has received a four-year, $1.1 million grant to explore using artificial intelligence and personalized learning to improve physician education.
Hoxworth Blood Center teams up with Cyclones in February for biggest blood drive event of year
January 30, 2026
Hoxworth Blood Center, University of Cincinnati, is teaming up with the Cyclones and other local businesses to host its annual Queen City Blood Drive on Feb. 9-11 at Heritage Bank Center. If you can’t attend this event, Hoxworth encourages you to still make donating a #HoxworthHabit and give blood this February.
Research findings may lead to new test for endometriosis
January 30, 2026
Endometriosis affects one in 10 women worldwide, and many go years before diagnosis. Symptoms include chronic pelvic pain, heavy bleeding during menstruation and/or sexual intercourse, bloating and fatigue. Katie Burns’ research at the University of Cincinnati is focused on creating a new, non-invasive test for endometriosis, using white blood cells as biomarkers. Burns, PhD, is an associate professor in the Department of Environmental and Public Health Sciences in the College of Medicine.